Washington Update

Fri, 2/19/10 - 12:03pm
0 Comments
1051 reads

Citation:

Pages 8 - 9

Post new comment

LATEST NEWS

FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
[Amylin] 1-31-12
FDA approves Voraxaze to treat patients with toxic methotrexate levels
[FDA] 1-17-12
FDA approves first generic version of cholesterol-lowering drug Lipitor
[FDA] 11-30-11
AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
[AHRQ] 11-17-11

Classified/Recruitment Opportunities

Advertise Your Job Here

How to Create Collegiality in a Difference of Opinion: Part 1

Neil Baum MD

2/3/12 | 0 Comments | 12 reads

Dutasteride vs Low Grade Prostate Cancer

Alvin B Lin MD FAAFP

1/31/12 | 0 Comments | 37 reads

Finding “Dr. Right” For Your Practice

Neil Baum MD

1/30/12 | 0 Comments | 40 reads

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications

Annals of Long Term Care

Search